BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33275876)

  • 1. Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.
    Hou C; Mandal A; Rohr J; Tsodikov OV
    Structure; 2021 May; 29(5):404-412.e4. PubMed ID: 33275876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1.
    Hou C; Weidenbach S; Cano KE; Wang Z; Mitra P; Ivanov DN; Rohr J; Tsodikov OV
    Nucleic Acids Res; 2016 Oct; 44(18):8990-9004. PubMed ID: 27587584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
    Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
    Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
    Martens JH; Mandoli A; Simmer F; Wierenga BJ; Saeed S; Singh AA; Altucci L; Vellenga E; Stunnenberg HG
    Blood; 2012 Nov; 120(19):4038-48. PubMed ID: 22983443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Basis for Dimerization and DNA Binding of Transcription Factor FLI1.
    Hou C; Tsodikov OV
    Biochemistry; 2015 Dec; 54(50):7365-74. PubMed ID: 26618620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.
    Looney AP; Han R; Stawski L; Marden G; Iwamoto M; Trojanowska M
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):121-131. PubMed ID: 28248553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mithramycin A Radiosensitizes EWS:Fli1
    Lin MY; Damron TA; Oest ME; Horton JA
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1454-1471. PubMed ID: 33373655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.
    Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer.
    Bilke S; Schwentner R; Yang F; Kauer M; Jug G; Walker RL; Davis S; Zhu YJ; Pineda M; Meltzer PS; Kovar H
    Genome Res; 2013 Nov; 23(11):1797-809. PubMed ID: 23940108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.
    Liu Y; Eckenrode JM; Zhang Y; Zhang J; Hayden RC; Kyomuhangi A; Ponomareva LV; Cui Z; Rohr J; Tsodikov OV; Van Lanen SG; Shaaban KA; Leggas M; Thorson JS
    J Med Chem; 2020 Nov; 63(22):14067-14086. PubMed ID: 33191745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
    Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
    J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.
    Grohar PJ; Glod J; Peer CJ; Sissung TM; Arnaldez FI; Long L; Figg WD; Whitcomb P; Helman LJ; Widemann BC
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):645-652. PubMed ID: 28735378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.
    Mitra P; Eckenrode JM; Mandal A; Jha AK; Salem SM; Leggas M; Rohr J
    J Med Chem; 2018 Sep; 61(17):8001-8016. PubMed ID: 30114371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
    Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
    Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
    Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
    Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.
    Tomlins SA; Palanisamy N; Brenner JC; Stall JN; Siddiqui J; Thomas DG; Lucas DR; Chinnaiyan AM; Kunju LP
    Am J Clin Pathol; 2013 Jun; 139(6):771-9. PubMed ID: 23690120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.
    Tajima S; Takashi Y; Ito N; Fukumoto S; Fukuyama M
    Med Mol Morphol; 2016 Dec; 49(4):203-209. PubMed ID: 26122367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
    Kim S; Denny CT; Wisdom R
    Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.